Paladin
Minds + Assembly Launches Assembled Intelligence and Adds Stratevi to Expand Market Access and HEOR Solutions
New York, NY — 10.23.2025 — Minds + Assembly, a leading healthcare marketing firm, today announced the launch of Assembled Intelligence, an integrated communications and commercialization platform designed to unite...
Endo faces industry-first FDA call to pull its opioid painkiller
Misuse of Opana ER has been associated with a ‘serious’ HIV and hep C outbreaks
Stada opens books to let formal bidding commence
Cinven, Advent International and Bain Capital now have opportunity to revise their bids
Advent tops Cinven offer for Stada as third suitor looms
Values the OTC and generics specialist at €3.6bn, with offer open until 27 February
Allergan adds Zeltiq to M&A roster in $2.48n deal
Expands aesthetic pharma business with “best-in-class” body contouring system
Seattle Genetics signs $2bn deal for Immunomedics’ cancer drug
Buys rights to breast cancer drug candidate that could be be in line for FDA approval by year end
Stada confirms Cinven as one of two takeover bidders
Private equity group offers €3.6bn for the generics and over-the-counter medicines manufacturer
Cello Health expands with Defined Health acquisition
Builds US presence with biotech-focused strategy specialist
Celgene pays $300m upfront for immunology start-up Delinia
Broadens its pipeline with autoimmune disease candidate due to start trials in 2018
J&J agrees $30bn deal to acquire Actelion
Swiss biotech to retain control of early-stage pipeline as J&J takes minority stake in R&D spin-out
Merck pays Vertex $230m upfront for cancer programmes
Licences four DNA damage and repair programmes with first-in-class or best-in-class potential
Ipsen buys cancer business from stripped down Merrimack
Deal includes pancreatic cancer therapy Onivyde which it hopes will gain first-line approval